Masakazu Fukuda1, Chifumi Moriyama2, Tadao Yamazaki2, Yoshimi Imaeda2, Akiko Koga2. 1. Production Engineering Department, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo, 115-8543, Japan. fukuda.masakazu76@chugai-pharm.co.jp. 2. Production Engineering Department, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo, 115-8543, Japan.
Abstract
PURPOSE: To investigate the relationship between viscosity of concentrated MAb solutions and particle size parameters obtained from small-angle X-ray scattering (SAXS). METHODS: The viscosity of three MAb solutions (MAb1, MAb2, and MAb3; 40-200 mg/mL) was measured by electromagnetically spinning viscometer. The protein interactions of MAb solutions (at 60 mg/mL) was evaluated by SAXS. The phase behavior of 60 mg/mL MAb solutions in a low-salt buffer was observed after 1 week storage at 25°C. RESULTS: The MAb1 solutions exhibited the highest viscosity among the three MAbs in the buffer containing 50 mM NaCl. Viscosity of MAb1 solutions decreased with increasing temperature, increasing salt concentration, and addition of amino acids. Viscosity of MAb1 solutions was lowest in the buffer containing histidine, arginine, and aspartic acid. Particle size parameters obtained from SAXS measurements correlated very well with the viscosity of MAb solutions at 200 mg/mL. MAb1 exhibited liquid-liquid phase separation at a low salt concentration. CONCLUSIONS: Simultaneous addition of basic and acidic amino acids effectively suppressed intermolecular attractive interactions and decreased viscosity of MAb1 solutions. SAXS can be performed using a small volume of samples; therefore, the particle size parameters obtained from SAXS at intermediate protein concentration could be used to screen for low viscosity antibodies in the early development stage.
PURPOSE: To investigate the relationship between viscosity of concentrated MAb solutions and particle size parameters obtained from small-angle X-ray scattering (SAXS). METHODS: The viscosity of three MAb solutions (MAb1, MAb2, and MAb3; 40-200 mg/mL) was measured by electromagnetically spinning viscometer. The protein interactions of MAb solutions (at 60 mg/mL) was evaluated by SAXS. The phase behavior of 60 mg/mL MAb solutions in a low-salt buffer was observed after 1 week storage at 25°C. RESULTS: The MAb1 solutions exhibited the highest viscosity among the three MAbs in the buffer containing 50 mM NaCl. Viscosity of MAb1 solutions decreased with increasing temperature, increasing salt concentration, and addition of amino acids. Viscosity of MAb1 solutions was lowest in the buffer containing histidine, arginine, and aspartic acid. Particle size parameters obtained from SAXS measurements correlated very well with the viscosity of MAb solutions at 200 mg/mL. MAb1 exhibited liquid-liquid phase separation at a low salt concentration. CONCLUSIONS: Simultaneous addition of basic and acidic amino acids effectively suppressed intermolecular attractive interactions and decreased viscosity of MAb1 solutions. SAXS can be performed using a small volume of samples; therefore, the particle size parameters obtained from SAXS at intermediate protein concentration could be used to screen for low viscosity antibodies in the early development stage.
Authors: Charlotte Rode Mosbæk; Petr V Konarev; Dmitri I Svergun; Christian Rischel; Bente Vestergaard Journal: Pharm Res Date: 2012-04-03 Impact factor: 4.200
Authors: John F Carpenter; Theodore W Randolph; Wim Jiskoot; Daan J A Crommelin; C Russell Middaugh; Gerhard Winter Journal: J Pharm Sci Date: 2010-05 Impact factor: 3.534
Authors: Frédéric Cardinaux; Emanuela Zaccarelli; Anna Stradner; Saskia Bucciarelli; Bela Farago; Stefan U Egelhaaf; Francesco Sciortino; Peter Schurtenberger Journal: J Phys Chem B Date: 2011-04-29 Impact factor: 2.991
Authors: Brian D Connolly; Chris Petry; Sandeep Yadav; Barthélemy Demeule; Natalie Ciaccio; Jamie M R Moore; Steven J Shire; Yatin R Gokarn Journal: Biophys J Date: 2012-07-03 Impact factor: 4.033
Authors: Branden A Salinas; Hasige A Sathish; Steven M Bishop; Nick Harn; John F Carpenter; Theodore W Randolph Journal: J Pharm Sci Date: 2010-01 Impact factor: 3.534
Authors: Jai A Pathak; Sean Nugent; Michael F. Bender; Christopher J Roberts; Robin J Curtis; Jack F Douglas Journal: Polymers (Basel) Date: 2021-02-17 Impact factor: 4.329